Fortfahren mit
Größe auswählen
| Größe/SKU | Verfügbarkeit | Preis |
|---|---|---|
150 mg | Warenkorb auf Verfügbarkeit prüfen | € 547,00 |
Über diesen Artikel
grade
pharmaceutical primary standard
agency
USP
API family
aprepitant
manufacturer/tradename
USP
application(s)
pharmaceutical
pharmaceutical
pharmaceutical (small molecule)
format
neat
SMILES string
FC1=CC=C([C@@H]([C@@H](O[C@H](C)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)OCC3)N3CC4=NNC(N4)=O)C=C1
InChI
1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19-,20+/m1/s1
InChI key
ATALOFNDEOCMKK-BYYRLHKVSA-N
General description
For further information and support please go to the website of the issuing Pharmacopoeia.
Analysis Note
Other Notes
1 of 1
Dieser Artikel | |||
|---|---|---|---|
| description United States Pharmacopeia (USP) Reference Standard | description European Pharmacopoeia (EP) Reference Standard | description certified reference material, pharmaceutical secondary standard | description ≥98% (HPLC) |
| manufacturer/tradename USP | manufacturer/tradename EDQM | manufacturer/tradename - | manufacturer/tradename - |
| grade pharmaceutical primary standard | grade pharmaceutical primary standard | grade certified reference material, pharmaceutical secondary standard | grade - |
| format neat | format - | format - | format - |
| application(s) pharmaceutical (small molecule) | application(s) - | application(s) pharmaceutical | application(s) - |
| agency USP | agency - | agency traceable to USP 1041904 | agency - |
| API family aprepitant | API family aprepitant | API family - | API family - |
Still not finding the right product?
Explore all of our products under Aprepitant
Lagerklasse
11 - Combustible Solids
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Hier finden Sie alle aktuellen Versionen:
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
